Marizyme Stock Odds of Future OTC Stock Price Finishing Over 59.51
| MRZM Stock | USD 0.04 0.01 20.00% |
Marizyme |
Marizyme Target Price Odds to finish over 59.51
The tendency of Marizyme OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 59.51 or more in 90 days |
| 0.04 | 90 days | 59.51 | close to zero percent |
Based on a normal probability distribution, the odds of Marizyme to move over $ 59.51 or more in 90 days from now is close to zero percent (This Marizyme probability density function shows the probability of Marizyme OTC Stock to fall within a particular range of prices over 90 days) . Probability of Marizyme price to stay between its current price of $ 0.04 and $ 59.51 at the end of the 90-day period is about 64.5 .
Given the investment horizon of 90 days Marizyme has a beta of -3.33. This indicates as returns on its benchmark rise, returns on holding Marizyme are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Marizyme is expected to outperform its benchmark. Moreover Marizyme has an alpha of 1.933, implying that it can generate a 1.93 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Marizyme Price Density |
| Price |
Predictive Modules for Marizyme
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Marizyme. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Marizyme Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Marizyme is not an exception. The market had few large corrections towards the Marizyme's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Marizyme, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Marizyme within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.93 | |
β | Beta against Dow Jones | -3.33 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.07 |
Marizyme Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Marizyme for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Marizyme can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Marizyme is way too risky over 90 days horizon | |
| Marizyme has some characteristics of a very speculative penny stock | |
| Marizyme appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 210.28 K. Net Loss for the year was (11 M) with profit before overhead, payroll, taxes, and interest of 129.93 K. | |
| Marizyme currently holds about 2.04 M in cash with (5.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Marizyme Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Marizyme OTC Stock often depends not only on the future outlook of the current and potential Marizyme's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Marizyme's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.5 M |
Marizyme Technical Analysis
Marizyme's future price can be derived by breaking down and analyzing its technical indicators over time. Marizyme OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Marizyme. In general, you should focus on analyzing Marizyme OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Marizyme Predictive Forecast Models
Marizyme's time-series forecasting models is one of many Marizyme's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Marizyme's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Marizyme
Checking the ongoing alerts about Marizyme for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Marizyme help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Marizyme is way too risky over 90 days horizon | |
| Marizyme has some characteristics of a very speculative penny stock | |
| Marizyme appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 210.28 K. Net Loss for the year was (11 M) with profit before overhead, payroll, taxes, and interest of 129.93 K. | |
| Marizyme currently holds about 2.04 M in cash with (5.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Marizyme OTC Stock
Marizyme financial ratios help investors to determine whether Marizyme OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marizyme with respect to the benefits of owning Marizyme security.